Bestrophin-2 and Aqueous Humor Dynamics
About the Research Project
Program
Award Type
Standard
Award Amount
$100,000
Active Dates
April 01, 2009 - March 31, 2011
Grant ID
G2009010
Acknowledgement
Goals
This study seeks to determine how the Bestrophin-2 protein controls the flow of the fluid in the eye, the aqueous humor.
Summary
We have recently identified the Bestrophin-2 protein (Best2) as a key regulator of fluid dynamics in the eye. This study will determine, via two specific aims, the mechanisms underlying this unique activity. If successful, this study will lead to new therapeutic options for treatment of glaucoma. Specific aims are
- To determine how Best2 functions to antagonize the formation of aqueous humor, the fluid found in the eye.
- To determine how absence of Best2 enhances outflow of aqueous humor from the eye.
Progress Updates
The goal of this study is to understand the role of bestrophin-2 (Best2) in regulating aqueous flow and drainage. To accomplish this, we have proposed two specific aims. The first was to determine how Best2 functions to antagonize the formation of aqueous humor. To this end, we have examined the distribution of Best2 in human eyes and found that, like in mice, Best2 is only expressed in the basal plasma membrane of non-pigmented epithelial (NPE) cells. NPE are cells of the ciliary body, a ring of tissue that encircles the lens that both controls its movement through tiny muscles and controls the passage of fluid between the front and back of the eye.
A more significant finding however, is that Best2 physiologically carries a bicarbonate conductance in certain cells and that this conductance is absent in mice deficient in Best2. A bicarbonate conductance is an electrical signal that’s produced in cells by the movement of the bicarbonate chemical across a cell membrane, allowing cells to communicate with each other. This strongly suggests that Best2 functions to carry a bicarbonate conductance in the NPE as well. This indicates that the entire bestrophin family of proteins may be involved in regulating bicarbonate transport.
Our second specific aim was to determine how absence of Best2 enhances outflow. We are currently examining levels of bioactive peptides in order to meet the goals of this aim.
Related Grants
National Glaucoma Research
Assessment of Vascular Resistance in Glaucoma
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Brad Fortune, OD, PhD
Current Organization
Legacy Devers Eye Institute
Assessment of Vascular Resistance in Glaucoma
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Brad Fortune, OD, PhD
Current Organization
Legacy Devers Eye Institute
National Glaucoma Research
Interleukin-10 As a Neuroprotective Factor in Glaucoma
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Tatjana Jakobs, MD
Current Organization
The Schepens Eye Research Institute, Mass. Eye and Ear
Interleukin-10 As a Neuroprotective Factor in Glaucoma
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Tatjana Jakobs, MD
Current Organization
The Schepens Eye Research Institute, Mass. Eye and Ear
National Glaucoma Research
From Resilience to Vulnerability: How Stress Accelerates Aging
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Dorota Skowronska-Krawczyk, PhD
Current Organization
University Of California, Irvine
From Resilience to Vulnerability: How Stress Accelerates Aging
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Dorota Skowronska-Krawczyk, PhD
Current Organization
University Of California, Irvine